Wall Street Associates’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Wall Street Associates’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-23,934	Closed	-$1.23M	–	287
2015 Q4	$1.23M	Sell	23,934 -600	-2%	-$29.1K	0.35%	105
2015 Q3	$1.05M	Sell	24,534 -2,800	-10%	-$135K	0.2%	135
2015 Q2	$1.25M	Sell	27,334 -7,600	-22%	-$306K	0.12%	184
2015 Q1	$1.33M	Sell	34,934 -700	-2%	-$24K	0.13%	186
2014 Q4	$1.01M	Buy	+35,634	New	+$991K	0.1%	202

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wall Street Associates's PTLA Position: Q1 2016 in Review

Wall Street Associates sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2016, closing a stake of 23,934 shares — an estimated $1.23M sold.

Wall Street Associates first reported a position in PTLA in Q4 2014 and held it in 5 quarters. The position peaked at $1.33M in Q1 2015. 167 funds tracked by Wall St. Rank hold PTLA as of Q1 2016.

Wall Street Associates reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Wall Street Associates sold 23,934 Portola Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1.23M.
Wall Street Associates first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 5 quarters.
Wall Street Associates's Portola Pharmaceuticals, Inc. position peaked at $1.33M in Q1 2015.
167 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2016.

Based on Wall Street Associates's 13F filing for Q1 2016, filed 13 May 2016.